Skip to main content
Erschienen in: Endocrine 1/2012

01.02.2012 | Original Article

Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study

verfasst von: Wen-jin Fu, Shi-long Xiong, Yao-gao Fang, Shu Wen, Mei-lian Chen, Ren-tang Deng, Lei Zheng, Shao-bo Wang, Lan-fen Pen, Qian Wang

Erschienen in: Endocrine | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate the prevalence of tubular damage in short-term (less than five years) type 2 diabetes mellitus (T2DM) patients and to explore the correlation between tubular markers and their relationship with renal indices at different stages of diabetic nephropathy. A group of 101 short-term T2DM patients and 28 control subjects were recruited. Tubular markers, such as neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-β-d-glucosaminidase (NAG), and kidney injury molecule 1 (KIM-1), as well as urinary albumin excretion were measured in voided urine. Glomerular filtration rate (GFR) was estimated via Macisaac’s formula. The patients were further categorized into three groups, namely, the normoalbuminuria, microalbuminuria, and macroalbuminuria groups, according to their urine albumin/creatinine ratio (UACR). Urinary tubular markers were compared and their correlations with renal indices [UACR and estimated GFR (eGFR)] were analyzed among the different diabetic groups. Compared with the control group, Urinary NGAL [median (IQR)][83.6(41.4−138.7) μg/gcr vs. 32.9(26.1−64.5) μg/gcr], NAG [13.5(8.7−17.9) U/gcr vs. 7.6(6.5−13.0) U/gcr] and KIM-1 [120.0(98.4−139.9) ng/gcr vs. 103.1(86.8−106.2) ng/gcr] in the T2DM were all markedly increased. For all patients, urinary NGAL had stronger positive correlations with UACR than NAG (R = 0.556 vs. 0.305, both P < 0.05). In addition, only urinary NGAL showed a negative correlation with eGFR (R = −0.215, P < 0.05). Urinary KIM-1, however, showed no significant difference among the three T2DM groups and did not correlate with either UACR or eGFR. As UACR increased from the normoalbuminuria to the last macroalbuminuria group, all of the markers increased. However, only the concentrations of NGAL were statistically different among the three diabetic groups. The correlation between the tubular markers and their relationships with the renal indices differed markedly among the three T2DM groups. In conclusion, these results suggest that tubular damage is common in short-term T2DM patients. Urinary NGAL may be a promising early marker for monitoring renal impairment in short-term T2DM patients.
Literatur
1.
Zurück zum Zitat M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)PubMedCrossRef M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)PubMedCrossRef
2.
Zurück zum Zitat M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)PubMedCrossRef M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)PubMedCrossRef
3.
Zurück zum Zitat P.A. Sarafidis, P.C. Stafylas, P.I. Georgianos et al., Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis. Am. J. Kidney Dis. 55, 835–847 (2010)PubMedCrossRef P.A. Sarafidis, P.C. Stafylas, P.I. Georgianos et al., Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis. Am. J. Kidney Dis. 55, 835–847 (2010)PubMedCrossRef
4.
Zurück zum Zitat J.L. Gross, M.J. de Azevedo, S.P. Silveiro et al., Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28, 164–176 (2005)PubMedCrossRef J.L. Gross, M.J. de Azevedo, S.P. Silveiro et al., Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28, 164–176 (2005)PubMedCrossRef
5.
Zurück zum Zitat V.S. Vaidya, M.A. Niewczas, L.H. Ficociello et al., Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-d-glucosaminidase. Kidney Int. 79, 464–470 (2011)PubMedCrossRef V.S. Vaidya, M.A. Niewczas, L.H. Ficociello et al., Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-d-glucosaminidase. Kidney Int. 79, 464–470 (2011)PubMedCrossRef
6.
Zurück zum Zitat G. Jerums, S. Panagiotopoulos, E. Premaratne et al., Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat. Rev. Nephrol. 5, 397–406 (2009)PubMedCrossRef G. Jerums, S. Panagiotopoulos, E. Premaratne et al., Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat. Rev. Nephrol. 5, 397–406 (2009)PubMedCrossRef
7.
Zurück zum Zitat A. Phillips, U. Janssen, J. Floege, Progression of diabetic nephropathy, Insights from cell culture studies and animal models. Kidney Blood Press Res. 22, 81–97 (1999)PubMedCrossRef A. Phillips, U. Janssen, J. Floege, Progression of diabetic nephropathy, Insights from cell culture studies and animal models. Kidney Blood Press Res. 22, 81–97 (1999)PubMedCrossRef
8.
Zurück zum Zitat R.E. Gilbert, M.E. Cooper, The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 56, 1627–1637 (1999)PubMedCrossRef R.E. Gilbert, M.E. Cooper, The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 56, 1627–1637 (1999)PubMedCrossRef
9.
Zurück zum Zitat M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Invest. 40, 95–102 (2010)CrossRef M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Invest. 40, 95–102 (2010)CrossRef
10.
Zurück zum Zitat S.E. Nielsen, T. Sugaya, L. Tarnow et al., Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care 32, 1684–1688 (2009)PubMedCrossRef S.E. Nielsen, T. Sugaya, L. Tarnow et al., Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care 32, 1684–1688 (2009)PubMedCrossRef
11.
Zurück zum Zitat K. Damman, D.J. Van Veldhuisen, G. Navis et al., Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96, 1297–1302 (2010)PubMedCrossRef K. Damman, D.J. Van Veldhuisen, G. Navis et al., Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96, 1297–1302 (2010)PubMedCrossRef
12.
Zurück zum Zitat D. Bolignano, V. Donato, G. Coppolino et al., Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am. J. Kidney Dis. 52, 595–605 (2008)PubMedCrossRef D. Bolignano, V. Donato, G. Coppolino et al., Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am. J. Kidney Dis. 52, 595–605 (2008)PubMedCrossRef
13.
Zurück zum Zitat J. Mishra, Q. Ma, C. Kelly et al., Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr. Nephrol. 21, 856–863 (2006)PubMedCrossRef J. Mishra, Q. Ma, C. Kelly et al., Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr. Nephrol. 21, 856–863 (2006)PubMedCrossRef
14.
Zurück zum Zitat C. Bazzi, C. Petrini, V. Rizza et al., Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol. Dial. Transplant. 17, 1890–1896 (2002)PubMedCrossRef C. Bazzi, C. Petrini, V. Rizza et al., Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol. Dial. Transplant. 17, 1890–1896 (2002)PubMedCrossRef
15.
Zurück zum Zitat O. Liangos, M.C. Perianayagam, V.S. Vaidya et al., Urinary N-acetyl-beta-(d)- glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 18, 904–912 (2007)PubMedCrossRef O. Liangos, M.C. Perianayagam, V.S. Vaidya et al., Urinary N-acetyl-beta-(d)- glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 18, 904–912 (2007)PubMedCrossRef
16.
Zurück zum Zitat H.K. Kang, D.K. Kim, B.H. Lee et al., Urinary N-acetyl-beta-d-glucosaminidase and malondialdehyde as a markers of renal damage in burned patients. J. Korean Med. Sci. 16, 598–602 (2001)PubMed H.K. Kang, D.K. Kim, B.H. Lee et al., Urinary N-acetyl-beta-d-glucosaminidase and malondialdehyde as a markers of renal damage in burned patients. J. Korean Med. Sci. 16, 598–602 (2001)PubMed
17.
Zurück zum Zitat F. Waanders, M.M. van Timmeren, C.A. Stegeman et al., Kidney injury molecule-1 in renal disease. J. Pathol. 220, 7–16 (2010)PubMedCrossRef F. Waanders, M.M. van Timmeren, C.A. Stegeman et al., Kidney injury molecule-1 in renal disease. J. Pathol. 220, 7–16 (2010)PubMedCrossRef
18.
Zurück zum Zitat T. Ichimura, J.V. Bonventre, V. Bailly et al., Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135–4142 (1998)PubMedCrossRef T. Ichimura, J.V. Bonventre, V. Bailly et al., Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135–4142 (1998)PubMedCrossRef
19.
Zurück zum Zitat T. Ichimura, C.C. Hung, S.A. Yang et al., Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal. Physiol. 286, F552–F563 (2004)PubMedCrossRef T. Ichimura, C.C. Hung, S.A. Yang et al., Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal. Physiol. 286, F552–F563 (2004)PubMedCrossRef
20.
Zurück zum Zitat E.W. Kuehn, K.M. Park, S. Somlo et al., Kidney injury molecule-1 expression in murine polycystic kidney disease. Am. J. Physiol. Renal. Physiol. 283, F1326–F1336 (2002)PubMed E.W. Kuehn, K.M. Park, S. Somlo et al., Kidney injury molecule-1 expression in murine polycystic kidney disease. Am. J. Physiol. Renal. Physiol. 283, F1326–F1336 (2002)PubMed
21.
Zurück zum Zitat V.S. Vaidya, V. Ramirez, T. Ichimura et al., Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal. Physiol. 290(2), F517–F529 (2006)PubMedCrossRef V.S. Vaidya, V. Ramirez, T. Ichimura et al., Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal. Physiol. 290(2), F517–F529 (2006)PubMedCrossRef
22.
Zurück zum Zitat J. Surendar, S. Anuradha, B. Ashley et al., Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32). Metab. Syndr. Relat. Disord. 7, 419–425 (2009)PubMedCrossRef J. Surendar, S. Anuradha, B. Ashley et al., Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32). Metab. Syndr. Relat. Disord. 7, 419–425 (2009)PubMedCrossRef
23.
Zurück zum Zitat R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)PubMedCrossRef R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)PubMedCrossRef
24.
Zurück zum Zitat E. Brocco, P. Fioretto, M. Mauer et al., Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int. 63, S40–S44 (1997) E. Brocco, P. Fioretto, M. Mauer et al., Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int. 63, S40–S44 (1997)
25.
Zurück zum Zitat M. Dalla, Vestra, A. Saller, E. Bortoloso et al., Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes. Metab. 26(Suppl), 8–14 (2000) M. Dalla, Vestra, A. Saller, E. Bortoloso et al., Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes. Metab. 26(Suppl), 8–14 (2000)
26.
Zurück zum Zitat Y. Yu, H. Jin, D. Holder et al., Biomarkers of kidney tubule injury: urinary trefoil factor 3 and albumin. Nat. Biotechnol. 28, 470–477 (2010)PubMedCrossRef Y. Yu, H. Jin, D. Holder et al., Biomarkers of kidney tubule injury: urinary trefoil factor 3 and albumin. Nat. Biotechnol. 28, 470–477 (2010)PubMedCrossRef
27.
Zurück zum Zitat L.M. Russo, R.M. Sandoval, S.B. Campos et al., Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 20, 489–494 (2009)PubMedCrossRef L.M. Russo, R.M. Sandoval, S.B. Campos et al., Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 20, 489–494 (2009)PubMedCrossRef
28.
Zurück zum Zitat Y.C. Ma, L. Zuo, J.H. Chen et al., Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 17, 2937–2944 (2006)PubMedCrossRef Y.C. Ma, L. Zuo, J.H. Chen et al., Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 17, 2937–2944 (2006)PubMedCrossRef
29.
Zurück zum Zitat P. Devarajan, Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert. Opin. Med. Diagn. 2(4), 387–398 (2008)PubMedCrossRef P. Devarajan, Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert. Opin. Med. Diagn. 2(4), 387–398 (2008)PubMedCrossRef
30.
Zurück zum Zitat S.E. Nielsen, K.J. Schjoedt, A.S. Astrup et al., Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet. Med. 27, 1144–1150 (2010)PubMedCrossRef S.E. Nielsen, K.J. Schjoedt, A.S. Astrup et al., Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet. Med. 27, 1144–1150 (2010)PubMedCrossRef
31.
Zurück zum Zitat S.E. Nielsen, S. Andersen, D. Zdunek et al., Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int. 79, 1113–1118 (2011)PubMedCrossRef S.E. Nielsen, S. Andersen, D. Zdunek et al., Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int. 79, 1113–1118 (2011)PubMedCrossRef
Metadaten
Titel
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study
verfasst von
Wen-jin Fu
Shi-long Xiong
Yao-gao Fang
Shu Wen
Mei-lian Chen
Ren-tang Deng
Lei Zheng
Shao-bo Wang
Lan-fen Pen
Qian Wang
Publikationsdatum
01.02.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9509-7

Weitere Artikel der Ausgabe 1/2012

Endocrine 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.